Avastin slows progress of breast cancer in trial

[News]

The addition of Genentech Inc's cancer drug Avastin to chemotherapyslows the progress of breast cancer at two different doses,according to results of a large international trial released onSaturday.

More... (http://www.healthcentral.com/breast-cancer/news-253395-66.html)